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Clinical Group
Abstract
Background: When liver bleeding cannot be controlled by conventional methods, a topical hemostatic 
patch can be applied during surgery. In recent years new hemostats have become available. The aim 
of this study was to investigate the degree of adhesion and infl ammation for three topical hemostatic 
patches, TachoSil®, Hemopatch™ and Veriset™.
Methods: In 60 adult male Sprague Dawley rats liver two lesions were induced with a scalpel. Each 
rat was treated with two of the three patches tested. After 1, 2 and 3 months the animals were euthanized 
and macroscopic evaluation of adhesions and histological assessment of infl ammation and macrophage 
infi ltration were performed.
Results: A signifi cant higher (p<0.05) occurrence of foreign body giant cells (FBGCs) was found in 
Hemopatch™ and Veriset™, whereas both had a lower degree of infl ammatory and macrophage infi ltration 
compared to TachoSil®. No differences in the occurrence of adhesions were found.
Conclusion: Our study found evidence for difference in infl ammation and formation of foreign body 
giant cells for the three hemostatic patches.
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Introduction
Bleeding during hepatic surgery is associated with a 
higher risk of morbidity and mortality and cannot always be 
controlled by compression, ligature or other conventional 
procedures [1-4]. The occurrence of bleeding during liver 
resections and liver transplantations is minimized due to 
new methods of resection, such as segmented resections and 
proximal hemostasis [5,6]. Hemostatic sealants and topical 
patches are now also widely used. In Denmark, three patches 
are available for this purpose. TachoSil® (Takeda, Austria) is a 
topical hemostatic patch for mild or moderate bleeding based 
on human fi brin and thrombin on an equine collagen patch 
[7]. Hemopatch™ (Baxter AG, Austria) is made from bovine 
collagen with reactive pentaerythritol polyethylene glycol ether 
tetra-succinimidyl glutarate (NHS-PEG) on the active side, 
which initiates the organisms own clotting mechanisms [8,9]. 
Veriset™ (Covidien, USA) is a cellulose matrix with a non-
specifi ed polyethylene glycol (PEG) on the active side [10,11]. 
The risk of adhesions has proven to be lower by topical 
hemostatic patches compared to conventional methods of 
hemostasis [12,13]. However, biomaterials cause a foreign 
body response, which is the end-stage response of the 
infl ammatory and wound healing responses, characterized by 
protein adsorption, macrophage adhesion and fusion of the 
macrophages into foreign body giant cells (FBGCs) [14]. FBGCs 
are found in larger numbers in adhesions, and indicative for 
adhesion formation [15].
The aim of our study was to compare three topical 
hemostatic patches with respect to occurrence of adhesion 
and infl ammation, macrophage infi ltration, and occurrence of 
FBGCs.
Materials and Methods
The study was designed as a randomised trial with 60 
adult male Sprague Dawley rats. The rats were divided in three 
groups of 20 rats. Each rat received 2 patches on 2 separate 
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liver lobes. The patches were divided through randomisation 
with all rats receiving 2 different patches. Two standardized 
lesions (diameter 1 mm) were made with a scalpel after surgical 
exposure of the liver on separate lobes, and a patch was applied 
on each location. One group was euthanized 1 months after 
surgery, a second group after 2 months and a third group was 
euthanized 3 months after surgery. One rat was euthanized 
preliminary due to post-operative complications, and not 
included in the study.
The study was approved by an ethical committee (Danish 
Animal Experiments Inspectorate, j.nr. 2012-15-2934-00129) 
and performed at approved animal facilities. 
Anaesthesia
The rats had a mean weight of 266 ± 19.4 grams (mean 
± SD) on the day of the operation. They were anaesthetized 
by SC injection of fentanyl 236 μg/kg, fl uanisone 7.5 mg/kg 
and midazolam 3.75 mg/kg. The rat was placed on a heated 
operating table and an SC injection with 3 ml was given and 
Viscotears applied on the eyes to prevent dehydration, whereas 
oxygen was supplied via a nose mask. 
Surgery
A 3 cm longitudinal midline incision was made from the 
Proc. xiphoideus and the abdominal wall was opened by blunt 
dissection. The liver lobe was held with cotton tip and a 
standardized lesion was made with an approximate diameter 
of 1 mm, ensuring to perforate the liver capsule and liver 
parenchyma. This always yielded a bleed, which is necessary 
for the patches to function. A patch measuring 20x20 mm was 
applied using the manufacturer’s instructions. In most cases 
this was enough to ensure hemostasis, but in some of the rats, 
application was diffi cult. The patch either slipped off or did not 
cover the lesion. In these cases the patch was reapplied. The 
abdominal wall was closed with a continuous suture with 4-0 
Vicryl suture (Ethicon, Belgium) and the skin was closed with 
6-10 clips (Visistat® Weck skin stapler 35w, Telefl ex Medical, 
USA).
Postoperative procedures
The rats were placed in individual cages for three days, 
and treated with buprinorphine (Temgesic, 40 μg/kg SC) for 
72 hours postoperatively every nine hours. They had access to 
standard rodent chow, water and Diet Gel® (Clear H20, USA). 
Hereafter they were placed in home cages, with four rats in 
each cage.
Necropsy
The rats were euthanized in pairs in a CO2 chamber which 
was gradually fi lled with oxygen 1 l/min and carbon dioxide 5 l/
min. and necropsy was performed. The degree of adhesion was 
scored according to Zühlke et al. [16], including dissemination 
from liver and patch area to the abdominal wall or other organs. 
The liver was extracted and preserved in a formalin solution. 
Histology
The livers were processed and stained with Haematoxylin 
Eosin and Sirius Red. The slides were scanned with a high-
resolution scanner from Hamamatsu (NanoZoomer 2.0-HT 
C9600, Photonics, Japan), 20x magnifi cation, and analysed 
using the software specifi c NPD-viewer (Viewing software, 
NDP.view2 U12388-01, Japan).
Occurrence of infl ammation (plasma cells and lymphocyte 
infi ltration) and macrophages in the inner and outer layer 
of the patch was scored and presence of FBGCs was graded. 
The occurence of fi brosis and neavascularization was included 
as well. Odds Ratios (OR) were calculated using the score for 
TachoSil as a reference. The OR for Hemopatch and Veriset was 
calculated as the deviation from the score of TachoSil.
Statistical analysis
We used non-parametric statistics for binary data. The 
statistical analysis was performed with Stata® 13.1 (StataCorp, 
USA). The tests used were 2, Fisher’s exact test and logistic 
regression. All data was converted to binary data to make the 
data easily interpretable and presentable.
Results
The degree of adhesion, including dissemination from 
liver and patch area to the abdominal wall or other organs is 
presented in table 1. No signifi cant differences were found. 
Occurrence of infl ammation (plasma cells and lymphocyte 
infi ltration) and macrophages in the inner and outer layer of 
the patch was scored and presence of FBGCs was graded, and 
presented as Odds Ratios with TachoSil as a reference. The 
results are presented in tables 2,3, together with the occurrence 
of fi brosis and neovascularization.
No differences were found between the groups euthanized 
after 1, 2 or 3 months, and consequently the results from 
the groups were pooled. TachoSil® had signifi cantly higher 
infl ammation scores than Hemopatch™ and Veriset™ for both 
inner and outer layer. Also, TachoSil® had a signifi cantly higher 
occurrence of macrophages than Hemopatch™ and Veriset™ 
for the inner layer, while no signifi cance was found for outer 
layer. FBGCs in the inner layer were found more often in 
Hemopatch™ and Veriset™ than in TachoSil®. No signifi cant 
differences between the patches were found for FBGCs in the 
outer layer.
Table 1: The degree of adhesion, including dissemination from liver and patch area 
to the abdominal wall or other organs.
Adhesion score Characteristics
0 No adhesions
1 Filmy adhesions separable by blunt dissection 
2
Stronger adhesions where blunt dissection is possible or partly 
sharp dissection is necessary. Minimal vascularisation
3
Strong adhesions where lysis is only possible by sharp dissection. 
Clear vascularisation
4
Very strong adhesions where lysis is only possible by sharp 
dissection. Organs strongly attached with severe adhesions and 
damage to organs hardly preventable
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Discussion
The pathophysiology of adhesion formation is not fully 
understood. It is believed that the formation of fi brin, an 
essential part of the coagulation cascade, acts as a scaffold for 
collagen deposition and neovascularisation. If the fi brin is not 
lysed within 5-7 days of surgery the temporary matrix persists 
and gradually becomes an organized peritoneal adhesion 
[17]. The three patches caused a similar degree of adhesion, 
so the different components of the patches, human fi brin 
and thrombin on an equine collagen in TachoSil®, NHS-PEG 
in Hemopatch™ and PEG in Veriset™ have no infl uence on 
adhesion formation.
According to Arung et al. [17,18], adhesion formation is 
the result of an infl ammatory response to tissue injury. Our 
study did not fi nd a positive association between markers 
of infl ammation and the formation of adhesions, even in a 
patch yielding a high amount of infl ammation. According to 
Nohuz et al. [12], TachoSil® is preventative in formation of 
adhesions in a rat model, where TachoSil® is tested against 
electrocoagulation. We could not confi rm this fi nding, since 
TachoSil® caused a similar level of adhesions as Hemopatch™ 
and Veriset™. However, results from rat studies cannot be 
necessarily extrapolated to humans due to the many factors 
that play a role in adhesion formation [19].
Hemopatch™ and Veriset™, both patches containing PEG, 
caused higher presence of FBGCs than TachoSil®. Anderson et 
al. [14], state that particles of non-specifi ed polyethylene from 
prosthesis and other biomaterials induce FBGC-formation, 
and explains this as the result of frustrated phagocytosis. 
FBGCs help degrading foreign bodies by releasing enzymes 
and reactive oxygen intermediates. Nagelschmidt et al. [20], 
showed that an intraperitoneal PEG-solution, given after a 
laparoscopic procedure, reduces the formation of adhesions, 
suggesting that PEG containing patches should cause fewer 
adherences. FBGCs are found in larger numbers in adhesions, 
and are indicative for adhesion formation [15], so it would be 
expected that Hemopatch™ and Veriset™ had lower levels of 
FBGCs if the PEG in these patches would reduce the formation 
of adhesions. The FBGC-reaction to PEG, and the importance of 
FBGCs in adhesion formation is an interesting area for further 
investigation.
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